摘要 |
<p>An isoxazol derivative, or its pharmacologically acceptable salt, having an excellent P38MAP kinase inhibiting potency, the pyrimidinylisoxazol derivative represented by the formula: wherein R<SUP>1</SUP> is a hydrogen atom, lower alkyl, amino, halogen atom, lower alkoxy, etc.; R<SUP>2</SUP> is a substituted or unsubstituted aryl, etc.; R<SUP>3</SUP> is a hydrogen atom or lower alkyl; R<SUP>4</SUP> is a substituted or unsubstituted phenyl, etc.; and Y is -CH<SUB>2</SUB>-, -CO-, -CH(CH<SUB>3</SUB>)-, -O-, -NH-, etc.</p> |
申请人 |
ASKA PHARMACEUTICAL CO., LTD.;HASUMI, KOICHI;OHTA, SHUJI;SAITO, TAKAHISA;SATO, SHUICHIRO;KATO, JUN-YA;SATO, JUN;SUZUKI, HIROYUKI;ASANO, HAJIME;OKADA, MAMI;MATSUMOTO, YASUHIRO;SHIROTA, KAZUHIKO |
发明人 |
HASUMI, KOICHI;OHTA, SHUJI;SAITO, TAKAHISA;SATO, SHUICHIRO;KATO, JUN-YA;SATO, JUN;SUZUKI, HIROYUKI;ASANO, HAJIME;OKADA, MAMI;MATSUMOTO, YASUHIRO;SHIROTA, KAZUHIKO |